Industry Research Reports

Home > Reports > Service & Software > Global Plasma and Serum Proteomics Analysis Service Market Research Report 2026

Global Plasma and Serum Proteomics Analysis Service Market Research Report 2026

Industry: Service & Software

Published Date: 2026-07-17

Pages: 201 Pages

Report ld: 6977452

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Plasma and Serum Proteomics Analysis Service Market Size(US$)

CAGR 2026-2032

12.0%

Market Size,2032

USD 1,629

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 823 million

Market Forecast in 2032(Value)

US$ 1,629 million

CAGR

12.0%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Plasma and Serum Proteomics Analysis Service market was valued at US$ 747 million in 2025 and is anticipated to reach US$ 1629 million by 2032, at a CAGR of 12.0% from 2026 to 2032.

Plasma and Serum Proteomics Analysis Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.

As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.

Plasma and Serum Proteomics Analysis Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.

These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.

Plasma and Serum Proteomics Analysis Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.

Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.

The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.

The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.

Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.

Plasma and Serum Proteomics Analysis Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.

As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.

The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.

The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.

Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.

Future demand for Plasma and Serum Proteomics Analysis Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.

Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.

With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.

This report delivers a comprehensive overview of the global Plasma and Serum Proteomics Analysis Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plasma and Serum Proteomics Analysis Service. The Plasma and Serum Proteomics Analysis Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Plasma and Serum Proteomics Analysis Service market comprehensively. Regional market sizes by Type, by Application, by End User, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Plasma and Serum Proteomics Analysis Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Plasma Proteomics Analysis Service
Serum Proteomics Analysis Service

Segment by Application

Disease Biomarker Research
Drug Development
Clinical Research
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End User, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Plasma and Serum Proteomics Analysis Service companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Plasma Proteomics Analysis Service

1.2.3 Serum Proteomics Analysis Service

1.3 Market by End User

1.3.1 Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by End User: 2021 vs 2025 vs 2032

1.3.2 Universities and Research Institutes

1.3.3 Hospitals

1.3.4 Pharmaceutical Companies

1.3.5 Others

1.4 Market by Research Areas

1.4.1 Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Research Areas: 2021 vs 2025 vs 2032

1.4.2 Oncology

1.4.3 Cardiovascular

1.4.4 Agriculture

1.4.5 Neuroscience

1.4.6 Other

1.5 Market by Application

1.5.1 Global Plasma and Serum Proteomics Analysis Service Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Disease Biomarker Research

1.5.3 Drug Development

1.5.4 Clinical Research

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Plasma and Serum Proteomics Analysis Service Market Perspective (2021–2032)

2.2 Global Plasma and Serum Proteomics Analysis Service Growth Trends by Region

2.2.1 Global Plasma and Serum Proteomics Analysis Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Plasma and Serum Proteomics Analysis Service Historic Market Size by Region (2021–2026)

2.2.3 Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Region (2027–2032)

2.3 Plasma and Serum Proteomics Analysis Service Market Dynamics

2.3.1 Plasma and Serum Proteomics Analysis Service Industry Trends

2.3.2 Plasma and Serum Proteomics Analysis Service Market Drivers

2.3.3 Plasma and Serum Proteomics Analysis Service Market Challenges

2.3.4 Plasma and Serum Proteomics Analysis Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Plasma and Serum Proteomics Analysis Service Players by Revenue

3.1.1 Global Top Plasma and Serum Proteomics Analysis Service Players by Revenue (2021–2026)

3.1.2 Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Plasma and Serum Proteomics Analysis Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Plasma and Serum Proteomics Analysis Service Revenue

3.4 Global Plasma and Serum Proteomics Analysis Service Market Concentration Ratio

3.4.1 Global Plasma and Serum Proteomics Analysis Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Plasma and Serum Proteomics Analysis Service Revenue in 2025

3.5 Global Key Players of Plasma and Serum Proteomics Analysis Service Head Offices and Areas Served

3.6 Global Key Players of Plasma and Serum Proteomics Analysis Service, Products and Applications

3.7 Global Key Players of Plasma and Serum Proteomics Analysis Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Plasma and Serum Proteomics Analysis Service Breakdown Data by Type

4.1 Global Plasma and Serum Proteomics Analysis Service Historic Market Size by Type (2021–2026)

4.2 Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Type (2027–2032)

5 Plasma and Serum Proteomics Analysis Service Breakdown Data by Application

5.1 Global Plasma and Serum Proteomics Analysis Service Historic Market Size by Application (2021–2026)

5.2 Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Plasma and Serum Proteomics Analysis Service Market Size (2021–2032)

6.2 North America Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Plasma and Serum Proteomics Analysis Service Market Size by Country (2021–2026)

6.4 North America Plasma and Serum Proteomics Analysis Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Plasma and Serum Proteomics Analysis Service Market Size (2021–2032)

7.2 Europe Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (2021–2026)

7.4 Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size (2021–2032)

8.2 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Plasma and Serum Proteomics Analysis Service Market Size (2021–2032)

9.2 Latin America Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Plasma and Serum Proteomics Analysis Service Market Size by Country (2021–2026)

9.4 Latin America Plasma and Serum Proteomics Analysis Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size (2021–2032)

10.2 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Olink (Thermo Fisher Scientific)

11.1.1 Olink (Thermo Fisher Scientific) Company Details

11.1.2 Olink (Thermo Fisher Scientific) Business Overview

11.1.3 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Introduction

11.1.4 Olink (Thermo Fisher Scientific) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.1.5 Olink (Thermo Fisher Scientific) Recent Development

11.2 SomaLogic (Illumina)

11.2.1 SomaLogic (Illumina) Company Details

11.2.2 SomaLogic (Illumina) Business Overview

11.2.3 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Introduction

11.2.4 SomaLogic (Illumina) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.2.5 SomaLogic (Illumina) Recent Development

11.3 Labcorp

11.3.1 Labcorp Company Details

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Plasma and Serum Proteomics Analysis Service Introduction

11.3.4 Labcorp Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.3.5 Labcorp Recent Development

11.4 BostonGene

11.4.1 BostonGene Company Details

11.4.2 BostonGene Business Overview

11.4.3 BostonGene Plasma and Serum Proteomics Analysis Service Introduction

11.4.4 BostonGene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.4.5 BostonGene Recent Development

11.5 CellCarta

11.5.1 CellCarta Company Details

11.5.2 CellCarta Business Overview

11.5.3 CellCarta Plasma and Serum Proteomics Analysis Service Introduction

11.5.4 CellCarta Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.5.5 CellCarta Recent Development

11.6 GENEWIZ (Azenta Life Sciences)

11.6.1 GENEWIZ (Azenta Life Sciences) Company Details

11.6.2 GENEWIZ (Azenta Life Sciences) Business Overview

11.6.3 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Introduction

11.6.4 GENEWIZ (Azenta Life Sciences) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.6.5 GENEWIZ (Azenta Life Sciences) Recent Development

11.7 CDI Labs

11.7.1 CDI Labs Company Details

11.7.2 CDI Labs Business Overview

11.7.3 CDI Labs Plasma and Serum Proteomics Analysis Service Introduction

11.7.4 CDI Labs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.7.5 CDI Labs Recent Development

11.8 Biognosys

11.8.1 Biognosys Company Details

11.8.2 Biognosys Business Overview

11.8.3 Biognosys Plasma and Serum Proteomics Analysis Service Introduction

11.8.4 Biognosys Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.8.5 Biognosys Recent Development

11.9 Discovery Life Sciences

11.9.1 Discovery Life Sciences Company Details

11.9.2 Discovery Life Sciences Business Overview

11.9.3 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Introduction

11.9.4 Discovery Life Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.9.5 Discovery Life Sciences Recent Development

11.10 Firalis Molecular Precision

11.10.1 Firalis Molecular Precision Company Details

11.10.2 Firalis Molecular Precision Business Overview

11.10.3 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Introduction

11.10.4 Firalis Molecular Precision Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.10.5 Firalis Molecular Precision Recent Development

11.11 Cell Signaling Technology (CST)

11.11.1 Cell Signaling Technology (CST) Company Details

11.11.2 Cell Signaling Technology (CST) Business Overview

11.11.3 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Introduction

11.11.4 Cell Signaling Technology (CST) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.11.5 Cell Signaling Technology (CST) Recent Development

11.12 Sampled (Infinity Biologix)

11.12.1 Sampled (Infinity Biologix) Company Details

11.12.2 Sampled (Infinity Biologix) Business Overview

11.12.3 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Introduction

11.12.4 Sampled (Infinity Biologix) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.12.5 Sampled (Infinity Biologix) Recent Development

11.13 APTBIO

11.13.1 APTBIO Company Details

11.13.2 APTBIO Business Overview

11.13.3 APTBIO Plasma and Serum Proteomics Analysis Service Introduction

11.13.4 APTBIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.13.5 APTBIO Recent Development

11.14 Sinotech Genomics

11.14.1 Sinotech Genomics Company Details

11.14.2 Sinotech Genomics Business Overview

11.14.3 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Introduction

11.14.4 Sinotech Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.14.5 Sinotech Genomics Recent Development

11.15 Biodesix

11.15.1 Biodesix Company Details

11.15.2 Biodesix Business Overview

11.15.3 Biodesix Plasma and Serum Proteomics Analysis Service Introduction

11.15.4 Biodesix Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.15.5 Biodesix Recent Development

11.16 Panome Bio

11.16.1 Panome Bio Company Details

11.16.2 Panome Bio Business Overview

11.16.3 Panome Bio Plasma and Serum Proteomics Analysis Service Introduction

11.16.4 Panome Bio Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.16.5 Panome Bio Recent Development

11.17 Novogene

11.17.1 Novogene Company Details

11.17.2 Novogene Business Overview

11.17.3 Novogene Plasma and Serum Proteomics Analysis Service Introduction

11.17.4 Novogene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.17.5 Novogene Recent Development

11.18 PTM BIO

11.18.1 PTM BIO Company Details

11.18.2 PTM BIO Business Overview

11.18.3 PTM BIO Plasma and Serum Proteomics Analysis Service Introduction

11.18.4 PTM BIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.18.5 PTM BIO Recent Development

11.19 BGI Genomics

11.19.1 BGI Genomics Company Details

11.19.2 BGI Genomics Business Overview

11.19.3 BGI Genomics Plasma and Serum Proteomics Analysis Service Introduction

11.19.4 BGI Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.19.5 BGI Genomics Recent Development

11.20 Evotec

11.20.1 Evotec Company Details

11.20.2 Evotec Business Overview

11.20.3 Evotec Plasma and Serum Proteomics Analysis Service Introduction

11.20.4 Evotec Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.20.5 Evotec Recent Development

11.21 Metware Biotechnology

11.21.1 Metware Biotechnology Company Details

11.21.2 Metware Biotechnology Business Overview

11.21.3 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Introduction

11.21.4 Metware Biotechnology Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.21.5 Metware Biotechnology Recent Development

11.22 MRM Proteomics

11.22.1 MRM Proteomics Company Details

11.22.2 MRM Proteomics Business Overview

11.22.3 MRM Proteomics Plasma and Serum Proteomics Analysis Service Introduction

11.22.4 MRM Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.22.5 MRM Proteomics Recent Development

11.23 Lc-Bio Technologies

11.23.1 Lc-Bio Technologies Company Details

11.23.2 Lc-Bio Technologies Business Overview

11.23.3 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Introduction

11.23.4 Lc-Bio Technologies Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.23.5 Lc-Bio Technologies Recent Development

11.24 Eurofins Scientific

11.24.1 Eurofins Scientific Company Details

11.24.2 Eurofins Scientific Business Overview

11.24.3 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Introduction

11.24.4 Eurofins Scientific Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.24.5 Eurofins Scientific Recent Development

11.25 MtoZ-Biolabs

11.25.1 MtoZ-Biolabs Company Details

11.25.2 MtoZ-Biolabs Business Overview

11.25.3 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Introduction

11.25.4 MtoZ-Biolabs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.25.5 MtoZ-Biolabs Recent Development

11.26 Creative Proteomics

11.26.1 Creative Proteomics Company Details

11.26.2 Creative Proteomics Business Overview

11.26.3 Creative Proteomics Plasma and Serum Proteomics Analysis Service Introduction

11.26.4 Creative Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.26.5 Creative Proteomics Recent Development

11.27 Macrogen

11.27.1 Macrogen Company Details

11.27.2 Macrogen Business Overview

11.27.3 Macrogen Plasma and Serum Proteomics Analysis Service Introduction

11.27.4 Macrogen Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.27.5 Macrogen Recent Development

11.28 TATAA Biocenter

11.28.1 TATAA Biocenter Company Details

11.28.2 TATAA Biocenter Business Overview

11.28.3 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Introduction

11.28.4 TATAA Biocenter Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.28.5 TATAA Biocenter Recent Development

11.29 OmicScouts (Momentum Biotechnologies)

11.29.1 OmicScouts (Momentum Biotechnologies) Company Details

11.29.2 OmicScouts (Momentum Biotechnologies) Business Overview

11.29.3 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Introduction

11.29.4 OmicScouts (Momentum Biotechnologies) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.29.5 OmicScouts (Momentum Biotechnologies) Recent Development

11.30 Precision Biomarker Laboratories (PBL)

11.30.1 Precision Biomarker Laboratories (PBL) Company Details

11.30.2 Precision Biomarker Laboratories (PBL) Business Overview

11.30.3 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Introduction

11.30.4 Precision Biomarker Laboratories (PBL) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.30.5 Precision Biomarker Laboratories (PBL) Recent Development

11.31 Shanghai OE Biotech

11.31.1 Shanghai OE Biotech Company Details

11.31.2 Shanghai OE Biotech Business Overview

11.31.3 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Introduction

11.31.4 Shanghai OE Biotech Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.31.5 Shanghai OE Biotech Recent Development

11.32 RxCelerate

11.32.1 RxCelerate Company Details

11.32.2 RxCelerate Business Overview

11.32.3 RxCelerate Plasma and Serum Proteomics Analysis Service Introduction

11.32.4 RxCelerate Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.32.5 RxCelerate Recent Development

11.33 Proteomics International

11.33.1 Proteomics International Company Details

11.33.2 Proteomics International Business Overview

11.33.3 Proteomics International Plasma and Serum Proteomics Analysis Service Introduction

11.33.4 Proteomics International Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.33.5 Proteomics International Recent Development

11.34 Proteome Sciences

11.34.1 Proteome Sciences Company Details

11.34.2 Proteome Sciences Business Overview

11.34.3 Proteome Sciences Plasma and Serum Proteomics Analysis Service Introduction

11.34.4 Proteome Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.34.5 Proteome Sciences Recent Development

11.35 Westlake Omics

11.35.1 Westlake Omics Company Details

11.35.2 Westlake Omics Business Overview

11.35.3 Westlake Omics Plasma and Serum Proteomics Analysis Service Introduction

11.35.4 Westlake Omics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.35.5 Westlake Omics Recent Development

11.36 Crown Bioscience

11.36.1 Crown Bioscience Company Details

11.36.2 Crown Bioscience Business Overview

11.36.3 Crown Bioscience Plasma and Serum Proteomics Analysis Service Introduction

11.36.4 Crown Bioscience Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.36.5 Crown Bioscience Recent Development

11.37 VProteomics

11.37.1 VProteomics Company Details

11.37.2 VProteomics Business Overview

11.37.3 VProteomics Plasma and Serum Proteomics Analysis Service Introduction

11.37.4 VProteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.37.5 VProteomics Recent Development

11.38 Shanghai Majorbio Bio-Pharm

11.38.1 Shanghai Majorbio Bio-Pharm Company Details

11.38.2 Shanghai Majorbio Bio-Pharm Business Overview

11.38.3 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Introduction

11.38.4 Shanghai Majorbio Bio-Pharm Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.38.5 Shanghai Majorbio Bio-Pharm Recent Development

11.39 Applied Biomics

11.39.1 Applied Biomics Company Details

11.39.2 Applied Biomics Business Overview

11.39.3 Applied Biomics Plasma and Serum Proteomics Analysis Service Introduction

11.39.4 Applied Biomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.39.5 Applied Biomics Recent Development

11.40 Sapient Bioanalytics

11.40.1 Sapient Bioanalytics Company Details

11.40.2 Sapient Bioanalytics Business Overview

11.40.3 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Introduction

11.40.4 Sapient Bioanalytics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

11.40.5 Sapient Bioanalytics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Plasma Proteomics Analysis Service

Table 3. Key Players of Serum Proteomics Analysis Service

Table 4. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by End User (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Universities and Research Institutes

Table 6. Key Players of Hospitals

Table 7. Key Players of Pharmaceutical Companies

Table 8. Key Players of Others

Table 9. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Research Areas (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Oncology

Table 11. Key Players of Cardiovascular

Table 12. Key Players of Agriculture

Table 13. Key Players of Neuroscience

Table 14. Key Players of Other

Table 15. Global Plasma and Serum Proteomics Analysis Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global Plasma and Serum Proteomics Analysis Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Plasma and Serum Proteomics Analysis Service Market Size by Region (US$ Million), 2021–2026

Table 18. Global Plasma and Serum Proteomics Analysis Service Market Share by Region (2021–2026)

Table 19. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 20. Global Plasma and Serum Proteomics Analysis Service Market Share by Region (2027–2032)

Table 21. Plasma and Serum Proteomics Analysis Service Market Trends

Table 22. Plasma and Serum Proteomics Analysis Service Market Drivers

Table 23. Plasma and Serum Proteomics Analysis Service Market Challenges

Table 24. Plasma and Serum Proteomics Analysis Service Market Restraints

Table 25. Global Plasma and Serum Proteomics Analysis Service Revenue by Players (US$ Million), 2021–2026

Table 26. Global Plasma and Serum Proteomics Analysis Service Market Share by Players (2021–2026)

Table 27. Global Top Plasma and Serum Proteomics Analysis Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Plasma and Serum Proteomics Analysis Service Revenue, 2025

Table 28. Ranking of Global Top Plasma and Serum Proteomics Analysis Service Companies by Revenue (US$ Million) in 2025

Table 29. Global 5 Largest Players Market Share by Plasma and Serum Proteomics Analysis Service Revenue (CR5 and HHI), 2021–2026

Table 30. Global Key Players of Plasma and Serum Proteomics Analysis Service, Headquarters and Area Served

Table 31. Global Key Players of Plasma and Serum Proteomics Analysis Service, Products and Applications

Table 32. Global Key Players of Plasma and Serum Proteomics Analysis Service, Date of General Availability (GA)

Table 33. Mergers and Acquisitions, Expansion Plans

Table 34. Global Plasma and Serum Proteomics Analysis Service Market Size by Type (US$ Million), 2021–2026

Table 35. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2021–2026)

Table 36. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 37. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2027–2032)

Table 38. Global Plasma and Serum Proteomics Analysis Service Market Size by Application (US$ Million), 2021–2026

Table 39. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2021–2026)

Table 40. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 41. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2027–2032)

Table 42. North America Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. North America Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2021–2026

Table 44. North America Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2027–2032

Table 45. Europe Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2021–2026

Table 47. Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2027–2032

Table 48. Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 49. Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region (US$ Million), 2021–2026

Table 50. Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region (US$ Million), 2027–2032

Table 51. Latin America Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Latin America Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2021–2026

Table 53. Latin America Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2027–2032

Table 54. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2021–2026

Table 56. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (US$ Million), 2027–2032

Table 57. Olink (Thermo Fisher Scientific) Company Details

Table 58. Olink (Thermo Fisher Scientific) Business Overview

Table 59. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product

Table 60. Olink (Thermo Fisher Scientific) Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 61. Olink (Thermo Fisher Scientific) Recent Development

Table 62. SomaLogic (Illumina) Company Details

Table 63. SomaLogic (Illumina) Business Overview

Table 64. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product

Table 65. SomaLogic (Illumina) Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 66. SomaLogic (Illumina) Recent Development

Table 67. Labcorp Company Details

Table 68. Labcorp Business Overview

Table 69. Labcorp Plasma and Serum Proteomics Analysis Service Product

Table 70. Labcorp Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 71. Labcorp Recent Development

Table 72. BostonGene Company Details

Table 73. BostonGene Business Overview

Table 74. BostonGene Plasma and Serum Proteomics Analysis Service Product

Table 75. BostonGene Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 76. BostonGene Recent Development

Table 77. CellCarta Company Details

Table 78. CellCarta Business Overview

Table 79. CellCarta Plasma and Serum Proteomics Analysis Service Product

Table 80. CellCarta Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 81. CellCarta Recent Development

Table 82. GENEWIZ (Azenta Life Sciences) Company Details

Table 83. GENEWIZ (Azenta Life Sciences) Business Overview

Table 84. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product

Table 85. GENEWIZ (Azenta Life Sciences) Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 86. GENEWIZ (Azenta Life Sciences) Recent Development

Table 87. CDI Labs Company Details

Table 88. CDI Labs Business Overview

Table 89. CDI Labs Plasma and Serum Proteomics Analysis Service Product

Table 90. CDI Labs Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 91. CDI Labs Recent Development

Table 92. Biognosys Company Details

Table 93. Biognosys Business Overview

Table 94. Biognosys Plasma and Serum Proteomics Analysis Service Product

Table 95. Biognosys Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 96. Biognosys Recent Development

Table 97. Discovery Life Sciences Company Details

Table 98. Discovery Life Sciences Business Overview

Table 99. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product

Table 100. Discovery Life Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 101. Discovery Life Sciences Recent Development

Table 102. Firalis Molecular Precision Company Details

Table 103. Firalis Molecular Precision Business Overview

Table 104. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product

Table 105. Firalis Molecular Precision Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 106. Firalis Molecular Precision Recent Development

Table 107. Cell Signaling Technology (CST) Company Details

Table 108. Cell Signaling Technology (CST) Business Overview

Table 109. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product

Table 110. Cell Signaling Technology (CST) Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 111. Cell Signaling Technology (CST) Recent Development

Table 112. Sampled (Infinity Biologix) Company Details

Table 113. Sampled (Infinity Biologix) Business Overview

Table 114. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product

Table 115. Sampled (Infinity Biologix) Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 116. Sampled (Infinity Biologix) Recent Development

Table 117. APTBIO Company Details

Table 118. APTBIO Business Overview

Table 119. APTBIO Plasma and Serum Proteomics Analysis Service Product

Table 120. APTBIO Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 121. APTBIO Recent Development

Table 122. Sinotech Genomics Company Details

Table 123. Sinotech Genomics Business Overview

Table 124. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product

Table 125. Sinotech Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 126. Sinotech Genomics Recent Development

Table 127. Biodesix Company Details

Table 128. Biodesix Business Overview

Table 129. Biodesix Plasma and Serum Proteomics Analysis Service Product

Table 130. Biodesix Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 131. Biodesix Recent Development

Table 132. Panome Bio Company Details

Table 133. Panome Bio Business Overview

Table 134. Panome Bio Plasma and Serum Proteomics Analysis Service Product

Table 135. Panome Bio Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 136. Panome Bio Recent Development

Table 137. Novogene Company Details

Table 138. Novogene Business Overview

Table 139. Novogene Plasma and Serum Proteomics Analysis Service Product

Table 140. Novogene Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 141. Novogene Recent Development

Table 142. PTM BIO Company Details

Table 143. PTM BIO Business Overview

Table 144. PTM BIO Plasma and Serum Proteomics Analysis Service Product

Table 145. PTM BIO Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 146. PTM BIO Recent Development

Table 147. BGI Genomics Company Details

Table 148. BGI Genomics Business Overview

Table 149. BGI Genomics Plasma and Serum Proteomics Analysis Service Product

Table 150. BGI Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 151. BGI Genomics Recent Development

Table 152. Evotec Company Details

Table 153. Evotec Business Overview

Table 154. Evotec Plasma and Serum Proteomics Analysis Service Product

Table 155. Evotec Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 156. Evotec Recent Development

Table 157. Metware Biotechnology Company Details

Table 158. Metware Biotechnology Business Overview

Table 159. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product

Table 160. Metware Biotechnology Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 161. Metware Biotechnology Recent Development

Table 162. MRM Proteomics Company Details

Table 163. MRM Proteomics Business Overview

Table 164. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product

Table 165. MRM Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 166. MRM Proteomics Recent Development

Table 167. Lc-Bio Technologies Company Details

Table 168. Lc-Bio Technologies Business Overview

Table 169. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product

Table 170. Lc-Bio Technologies Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 171. Lc-Bio Technologies Recent Development

Table 172. Eurofins Scientific Company Details

Table 173. Eurofins Scientific Business Overview

Table 174. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product

Table 175. Eurofins Scientific Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 176. Eurofins Scientific Recent Development

Table 177. MtoZ-Biolabs Company Details

Table 178. MtoZ-Biolabs Business Overview

Table 179. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product

Table 180. MtoZ-Biolabs Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 181. MtoZ-Biolabs Recent Development

Table 182. Creative Proteomics Company Details

Table 183. Creative Proteomics Business Overview

Table 184. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product

Table 185. Creative Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 186. Creative Proteomics Recent Development

Table 187. Macrogen Company Details

Table 188. Macrogen Business Overview

Table 189. Macrogen Plasma and Serum Proteomics Analysis Service Product

Table 190. Macrogen Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 191. Macrogen Recent Development

Table 192. TATAA Biocenter Company Details

Table 193. TATAA Biocenter Business Overview

Table 194. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product

Table 195. TATAA Biocenter Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 196. TATAA Biocenter Recent Development

Table 197. OmicScouts (Momentum Biotechnologies) Company Details

Table 198. OmicScouts (Momentum Biotechnologies) Business Overview

Table 199. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product

Table 200. OmicScouts (Momentum Biotechnologies) Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 201. OmicScouts (Momentum Biotechnologies) Recent Development

Table 202. Precision Biomarker Laboratories (PBL) Company Details

Table 203. Precision Biomarker Laboratories (PBL) Business Overview

Table 204. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product

Table 205. Precision Biomarker Laboratories (PBL) Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 206. Precision Biomarker Laboratories (PBL) Recent Development

Table 207. Shanghai OE Biotech Company Details

Table 208. Shanghai OE Biotech Business Overview

Table 209. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product

Table 210. Shanghai OE Biotech Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 211. Shanghai OE Biotech Recent Development

Table 212. RxCelerate Company Details

Table 213. RxCelerate Business Overview

Table 214. RxCelerate Plasma and Serum Proteomics Analysis Service Product

Table 215. RxCelerate Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 216. RxCelerate Recent Development

Table 217. Proteomics International Company Details

Table 218. Proteomics International Business Overview

Table 219. Proteomics International Plasma and Serum Proteomics Analysis Service Product

Table 220. Proteomics International Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 221. Proteomics International Recent Development

Table 222. Proteome Sciences Company Details

Table 223. Proteome Sciences Business Overview

Table 224. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product

Table 225. Proteome Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 226. Proteome Sciences Recent Development

Table 227. Westlake Omics Company Details

Table 228. Westlake Omics Business Overview

Table 229. Westlake Omics Plasma and Serum Proteomics Analysis Service Product

Table 230. Westlake Omics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 231. Westlake Omics Recent Development

Table 232. Crown Bioscience Company Details

Table 233. Crown Bioscience Business Overview

Table 234. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product

Table 235. Crown Bioscience Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 236. Crown Bioscience Recent Development

Table 237. VProteomics Company Details

Table 238. VProteomics Business Overview

Table 239. VProteomics Plasma and Serum Proteomics Analysis Service Product

Table 240. VProteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 241. VProteomics Recent Development

Table 242. Shanghai Majorbio Bio-Pharm Company Details

Table 243. Shanghai Majorbio Bio-Pharm Business Overview

Table 244. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product

Table 245. Shanghai Majorbio Bio-Pharm Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 246. Shanghai Majorbio Bio-Pharm Recent Development

Table 247. Applied Biomics Company Details

Table 248. Applied Biomics Business Overview

Table 249. Applied Biomics Plasma and Serum Proteomics Analysis Service Product

Table 250. Applied Biomics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 251. Applied Biomics Recent Development

Table 252. Sapient Bioanalytics Company Details

Table 253. Sapient Bioanalytics Business Overview

Table 254. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product

Table 255. Sapient Bioanalytics Revenue in Plasma and Serum Proteomics Analysis Service Business (US$ Million), 2021–2026

Table 256. Sapient Bioanalytics Recent Development

Table 257. Research Programs/Design for This Report

Table 258. Key Data Information from Secondary Sources

Table 259. Key Data Information from Primary Sources

Table 260. Authors List of This Report

List of Figures

Figure 1. Plasma and Serum Proteomics Analysis Service Picture

Figure 2. Global Plasma and Serum Proteomics Analysis Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Plasma and Serum Proteomics Analysis Service Market Share by Type: 2025 vs 2032

Figure 4. Plasma Proteomics Analysis Service Features

Figure 5. Serum Proteomics Analysis Service Features

Figure 6. Global Plasma and Serum Proteomics Analysis Service Market Size Comparison by End User (US$ Million), 2021–2032

Figure 7. Universities and Research Institutes Features

Figure 8. Hospitals Features

Figure 9. Pharmaceutical Companies Features

Figure 10. Others Features

Figure 11. Global Plasma and Serum Proteomics Analysis Service Market Size Comparison by Research Areas (US$ Million), 2021–2032

Figure 12. Oncology Features

Figure 13. Cardiovascular Features

Figure 14. Agriculture Features

Figure 15. Neuroscience Features

Figure 16. Other Features

Figure 17. Global Plasma and Serum Proteomics Analysis Service Market Size by Application (US$ Million), 2021–2032

Figure 18. Global Plasma and Serum Proteomics Analysis Service Market Share by Application: 2025 vs 2032

Figure 19. Disease Biomarker Research Case Studies

Figure 20. Drug Development Case Studies

Figure 21. Clinical Research Case Studies

Figure 22. Others Case Studies

Figure 23. Plasma and Serum Proteomics Analysis Service Report Years Considered

Figure 24. Global Plasma and Serum Proteomics Analysis Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 25. Global Plasma and Serum Proteomics Analysis Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 26. Global Plasma and Serum Proteomics Analysis Service Market Share by Region: 2025 vs 2032

Figure 27. Global Plasma and Serum Proteomics Analysis Service Market Share by Players in 2025

Figure 28. Global Plasma and Serum Proteomics Analysis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. The Top 10 and 5 Players Market Share by Plasma and Serum Proteomics Analysis Service Revenue in 2025

Figure 30. North America Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. North America Plasma and Serum Proteomics Analysis Service Market Share by Country (2021–2032)

Figure 32. United States Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Canada Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Europe Plasma and Serum Proteomics Analysis Service Market Share by Country (2021–2032)

Figure 36. Germany Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. France Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. U.K. Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Italy Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Russia Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Ireland Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Share by Region (2021–2032)

Figure 44. China Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Japan Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. South Korea Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. India Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Australia & New Zealand Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Latin America Plasma and Serum Proteomics Analysis Service Market Share by Country (2021–2032)

Figure 52. Mexico Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Brazil Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Share by Country (2021–2032)

Figure 56. Israel Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Saudi Arabia Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. UAE Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Olink (Thermo Fisher Scientific) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 60. SomaLogic (Illumina) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 61. Labcorp Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 62. BostonGene Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 63. CellCarta Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 64. GENEWIZ (Azenta Life Sciences) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 65. CDI Labs Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 66. Biognosys Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 67. Discovery Life Sciences Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 68. Firalis Molecular Precision Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 69. Cell Signaling Technology (CST) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 70. Sampled (Infinity Biologix) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 71. APTBIO Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 72. Sinotech Genomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 73. Biodesix Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 74. Panome Bio Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 75. Novogene Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 76. PTM BIO Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 77. BGI Genomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 78. Evotec Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 79. Metware Biotechnology Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 80. MRM Proteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 81. Lc-Bio Technologies Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 82. Eurofins Scientific Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 83. MtoZ-Biolabs Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 84. Creative Proteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 85. Macrogen Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 86. TATAA Biocenter Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 87. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 88. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 89. Shanghai OE Biotech Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 90. RxCelerate Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 91. Proteomics International Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 92. Proteome Sciences Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 93. Westlake Omics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 94. Crown Bioscience Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 95. VProteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 96. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 97. Applied Biomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 98. Sapient Bioanalytics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021–2026)

Figure 99. Bottom-up and Top-down Approaches for This Report

Figure 100. Data Triangulation

Figure 101. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Plasma and Serum Proteomics Analysis Service in 2026? zhanKai

The global market size of Plasma and Serum Proteomics Analysis Service in 2026 was 823 Million USD.

Which region is expected to have the highest market share? shouQi

What was the global market size of Plasma and Serum Proteomics Analysis Service in 2032? shouQi

What is the annual compound growth rate of the global Plasma and Serum Proteomics Analysis Service market size from 2026 to 2032? shouQi

Which companies rank high in the global Plasma and Serum Proteomics Analysis Service market? shouQi

Related Reports

Global Plasma and Serum Proteomics Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Plasma and Serum Proteomics Analysis Service market size was US$ 747 million in 2025 and is forecast to reach a readjusted size of US$ 1629 million by 2032 with a CAGR of 12.0% during the forecast period 2026-2032.
Published Date: 2026-07-17
Pages: 205
USD 4250.00
(Single User License)
Global Plasma and Serum Proteomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Plasma and Serum Proteomics Analysis Service market is projected to grow from US$ 747 million in 2025 to US$ 1629 million by 2032, at a CAGR of 12.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 199
USD 4900.00
(Single User License)
Plasma and Serum Proteomics Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Plasma and Serum Proteomics Analysis Service was estimated to be worth US$ 747 million in 2025 and is projected to reach US$ 1629 million, growing at a CAGR of 12.0% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 187
USD 3950.00
(Single User License)

Global Plasma and Serum Proteomics Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Plasma and Serum Proteomics Analysis Service market size was US$ 747 million in 2025 and is forecast to reach a readjusted size of US$ 1629 million by 2032 with a CAGR of 12.0% during the forecast period 2026-2032.
Published: 2026-07-17
Pages: 205
USD 4250.00 (Single User License)
Global Plasma and Serum Proteomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Plasma and Serum Proteomics Analysis Service market is projected to grow from US$ 747 million in 2025 to US$ 1629 million by 2032, at a CAGR of 12.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 199
USD 4900.00 (Single User License)
Plasma and Serum Proteomics Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Plasma and Serum Proteomics Analysis Service was estimated to be worth US$ 747 million in 2025 and is projected to reach US$ 1629 million, growing at a CAGR of 12.0% from 2026 to 2032.
Published: 2026-07-17
Pages: 187
USD 3950.00 (Single User License)